TSX:GUD (Knight Therapeutics Inc.)
About GUD
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Knight Therapeutics Inc. (TSX: GUD) Latest News
Dividend Stocks
TFSA: 3 Super Stocks That Can Make You Rich
Investing
Top TSX Stocks Under $10
Coronavirus
2 TSX Pharma Stocks That Can Make You a TFSA Millionaire
Investing
TFSA: 3 Healthcare Stocks That Can Make You Filthy Rich
Dividend Stocks
TFSA Investors: 2 Healthcare Stocks to Buy in May
Investing
TFSA Investors: 2 Growth Stocks I’m Buying If the Market Selloff Gets Worse
Investing
Canada’s Most Undervalued Pharmaceutical Stock Is a Buy!
Investing
Growth Investors: This Stock Could Easily Turn $10,000 Into $100,000
Investing
Revealed: 5 Top Growth Picks From This Award-Winning Mutual Fund
Investing
5 Reasons Why This Pharma Stock Is Poised for Takeoff
Investing
Can Knight Therapeutics Inc. Repeat the Success of Paladin Labs?
❮2